top of page
BIDMC Facility

Struggling with lingering symptoms after COVID-19?

You may be eligible for a new medication-free, virtual study offered through Beth Israel Deaconess Medical Center, using a mind-body approach to reduce or eliminate pain and other symptoms.

  • Who Qualifies For The Study?
    People between the ages of 18 and 65 with lingering symptoms after having COVID-19. Symptoms include but are not limited to, chronic fatigue, difficulty breathing, brain fog, joint pain, muscle pain, and headaches.
  • When Does The Study Start?
    The study recruits interested participants on a rolling basis. We are constantly seeking interested people.
  • Does It Cost Money To Participate?
    No. The study does not charge participants. Materials are provided for free of charge.
  • What Are The Eligible States For The Study?
    Alabama, Connecticut, Georgia, Illinois, Indiana, Iowa, Kansas, Kentucky, Maine, Maryland, Massachusetts, Michigan, Ohio, Tennessee, Texas, Vermont, Washington, and Wisconsin.
  • How Long Is the Study?
    The intervention lasts up to twelve weeks with sessions being held either once or twice a week. Each session lasts approximately 1.5 - 2 hours.
  • Who Funded The Study?
    This study is funded through an open philanthropic grant.
  • How Do I Find Out More Information?
    To find out more information, please fill out the interest survey found on the homepage of this site. You may also contact the study team at mindbodystudy@bidmc.harvard.edu or (617) 754-2882.

About Beth Israel Deaconess Medical Center

BIDMC is a world-class teaching hospital of Harvard Medical School and is located in the heart of Boston. We are passionate about caring for our patients like they are family, finding new cures, using the finest and the latest technologies, and teaching and inspiring caregivers of tomorrow. We put people at the center of everything we do, because we believe in medicine that puts people first.

bottom of page